These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7482433)

  • 21. Chylomicrons from patients with type V hyperlipoproteinemia inhibit platelet function.
    Aviram M; Furman B; Brook JG
    Atherosclerosis; 1985 Aug; 56(2):157-67. PubMed ID: 4074453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the aggregation responses of camel platelets.
    Al Ghumlas AK; Gader AG
    Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation.
    Doi H; Kugiyama K; Ohgushi M; Sugiyama S; Matsumura T; Ohta Y; Nakano T; Nakajima K; Yasue H
    Atherosclerosis; 1998 Apr; 137(2):341-9. PubMed ID: 9622277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of eicosapentaenoic acids on remnant-like particles, cholesterol concentrations and plasma fatty acid composition in patients with diabetes mellitus.
    Nakamura N; Hamazaki T; Kobayashi M; Ohta M; Okuda K
    In Vivo; 1998; 12(3):311-4. PubMed ID: 9706476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postprandial remnant lipoproteins as targets for the prevention of atherosclerosis.
    Nakajima K; Tanaka A
    Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):108-117. PubMed ID: 29493553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of collagen-induced aggregation of platelets in whole blood.
    Setiabudy-Dharma R; Funahara Y
    Thromb Res; 1986 Jun; 42(5):621-34. PubMed ID: 3715821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.
    Watanabe N; Taniguchi T; Taketoh H; Kitagawa Y; Namura H; Yoneda N; Kurimoto Y; Yamada S; Ishikawa Y
    Diabetes Care; 1999 Jan; 22(1):152-6. PubMed ID: 10333918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of VLDL, chylomicrons, and chylomicron remnants on platelet aggregability.
    Orth M; Luley C; Wieland H
    Thromb Res; 1995 Aug; 79(3):297-305. PubMed ID: 8533125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Searching for a new risk factor of sudden cardiac death].
    Takeichi S
    Nihon Hoigaku Zasshi; 1999 Nov; 53(3):255-75. PubMed ID: 10723958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet aggregation studies in whole human blood.
    Saniabadi AR; Lowe GD; Forbes CD; Prentice CR; Barbenel JC
    Thromb Res; 1983 Jun; 30(6):625-32. PubMed ID: 6412393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertriglyceridemia in pregnancy does not contribute to the enhanced formation of remnant lipoprotein particles.
    Okazaki M; Usui S; Tokunaga K; Nakajima Y; Takeichi S; Nakano T; Nakajima K
    Clin Chim Acta; 2004 Jan; 339(1-2):169-81. PubMed ID: 14687907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen.
    Ts'ao C
    Am J Pathol; 1976 Dec; 85(3):581-94. PubMed ID: 998732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of methylprednisolone and hydrocortisone on aggregation of rabbit platelets induced by arachidonic acid and other aggregating substances.
    Glass F; Lippton H; Kadowitz PJ
    Thromb Haemost; 1981 Dec; 46(4):676-9. PubMed ID: 6800048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C; Maiolo A; Tua A; Grignani G
    Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of remnant particles by immunoseparation: a new approach for investigation of postprandial lipoprotein metabolism in normolipidemic subjects.
    Schreuder PC; Twickler TB; Wang T; Nakajima K; Erkelens DW; Dallinga-Thie GM
    Atherosclerosis; 2001 Jul; 157(1):145-50. PubMed ID: 11427214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothesis: Postprandial remnant lipoproteins are the causal factors that induce the insulin resistance associated with obesity.
    Nakajima K; Tokita Y; Tanaka A
    Clin Chim Acta; 2018 Oct; 485():126-132. PubMed ID: 29958888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole blood platelet aggregation in humans and animals: a comparative study.
    Soloviev MV; Okazaki Y; Harasaki H
    J Surg Res; 1999 Apr; 82(2):180-7. PubMed ID: 10090827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoproteins and the inhibitory effect of human endothelial cells on platelet function.
    Nordøy A; Svensson B; Wiebe D; Hoak JC
    Circ Res; 1978 Oct; 43(4):527-34. PubMed ID: 210972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of human blood platelets with the 2',3'-dialdehyde and 2',3'-dialcohol derivatives of adenosine 5'-diphosphate and adenosine 5'-triphosphate.
    Pearce PH; Wright JM; Egan CM; Scrutton MC
    Eur J Biochem; 1978 Aug; 88(2):543-54. PubMed ID: 689037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.